Viewing Study NCT00486356


Ignite Creation Date: 2025-12-24 @ 11:14 PM
Ignite Modification Date: 2026-02-28 @ 5:31 AM
Study NCT ID: NCT00486356
Status: COMPLETED
Last Update Posted: 2024-01-03
First Post: 2007-06-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer
Sponsor: University of Nebraska
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 0284-04-FB
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View